Asia Pacific is estimated as the most opportunistic market for cell expansion owing to the increasing drug discovery activities, development of healthcare and biotechnology infrastructure
Albany, NY -- (SBWIRE) -- 11/25/2016 -- Cell expansion is defined as the production of daughter cells which arise originally from the single cell. Cell expansion is beneficial either therapeutically as drug screening tools or for core research purposes. Currently, cell expansion is majorly used for stem cells expansion which are transplanted in patients with blood cancer. Cell expansion also has a potential to be used in various diseases linked with genetic defects such as Parkinson's diseases or Alzheimer's disease. The cell expansion market can be differentiated into various segments on the basis of type of cells used for expansion and by applications. On the basis of type of cells used for expansion, the cell expansion market has been differentiated into three classes which include:
Download exclusive Sample of this report:
Human cells capture the major share of the cell expansion market on the basis of cell type. These cells are used for therapeutic applications for curing various types of cancers and genetic disorders. Human cells market could further be segmented into two classes which include stem cells and differentiated cells. Animal cell expansion on other hand is used for very less therapeutic applications however; plant cell expansion is currently under research activities for therapeutic applications. On the basis of applications, the cell expansion market has been classified as follows:
Stem cell research
Biotechnology and biopharmaceuticals
Stem cell research dominates the cell expansion factors. Extensive use of stem cells for therapeutic cancer and genetic diseases involves the extensive cell expansion procedure. Biotechnology and biopharmaceutical research also involves the cell expansion to a high extent. Recently, GE Healthcare has launched a cell expansion technology, Xuri W25 that is designed to develop T-cell and is used for performing T-cell therapies. Cell expansion based cellular regenerative medicines are used majorly for developing medicines for cardiovascular and neurological diseases.
View exclusive Global strategic Business report :
Geographically, cell expansion market is differentiated into four classes including North America, Europe, Asia Pacific and Rest of the World (RoW). North America followed by Europe dominates the cell expansion market due to extensive research and development activities, well-defined infrastructure investment supporting facilities and large government funding towards stem cell research. As a part of the Seventh Framework Programme for Research and Technological Development, the European Union funded four stem cell projects: HumEn, Neurostemcellrepair, PluriMes and ThymiStem. Similarly, in North America, Becton, Dickinson and Company granted a total of USD 100,000 worth of reagents used in research annually to 10 scientists for stem cell research. Increasing stem cell research activities has extended the use of cell expansion, hence driving the market. Asia Pacific is estimated as the most opportunistic market for cell expansion owing to the increasing drug discovery activities, development of healthcare and biotechnology infrastructure for various kinds of research and increase in outsourcing biotechnology processes in this region. For instance, the Government of India established a research institute specifically for drug development named Open Source Drug Discovery (OSDD), and invested USD 12 million for OSDD projects from 2008 to 2012. Perpetually increasing investments in drug discovery projects result in increased use of cell expansion, thus leading market growth.
Some of the major players of cell expansion market include Danaher Corporation, Corning Incorporated, Merck Millipore, Sigma-Aldrich Corporation, Terumo Corporation, Miltenyi Biotech, StemCell Technologies and Thermo Fisher Scientific, Inc.